10-Q: Atlantic American Swings to Profit in Q2 2025

Atlantic American Corporation reported a significant turnaround to net income in Q2 2025, driven by strong premium growth and improved underwriting in its life and health segment.

Summary

• Net income for the six months ended June 30, 2025, was $4.118 million, a substantial improvement from a net loss of $2.682 million in the prior year period.
• Diluted earnings per common share for the six months ended June 30, 2025, was $0.19, compared to a loss of $0.14 in the same period last year.
• Total revenue increased by 11.4% to $105.415 million for the six months ended June 30, 2025, up from $94.665 million in the comparable period of 2024.
• Net insurance premiums grew by 8.4% to $97.059 million for the six months ended June 30, 2025.
• Operating income (non-GAAP) for the six months ended June 30, 2025, was $1.859 million, a significant increase from an operating loss of $3.497 million in the prior year.
• Cash and cash equivalents increased to $46.423 million as of June 30, 2025, from $35.570 million at December 31, 2024.
• Total assets increased to $429.339 million as of June 30, 2025, from $393.428 million at December 31, 2024.
• Shareholders' equity increased to $106.168 million as of June 30, 2025, from $99.613 million at December 31, 2024.

Sentiment

Score: 7

Explanation: The company demonstrated a strong financial turnaround with significant net income and revenue growth, particularly in its life and health segment. Cash position improved, and the revolving credit facility was extended. However, the ongoing material weakness in internal controls and the deteriorating underwriting performance in the property and casualty segment temper the overall positive sentiment.

Positives

• Achieved a significant swing from a net loss to a net income of $4.118 million for the six months ended June 30, 2025.
• Reported strong revenue growth, with total revenue increasing 11.4% and net insurance premiums up 8.4% for the six-month period.
• Bankers Fidelity (Life & Health segment) showed substantial improvement, moving from an underwriting loss of $3.344 million to an underwriting income of $2.304 million, with its combined ratio improving from 106.2% to 96.0%.
• Bankers Fidelity's loss ratio decreased significantly from 67.8% to 60.7% due to lower utilization within the Medicare supplement line of business.
• Increased cash and cash equivalents by $10.853 million, primarily from operating activities and investment sales.
• Unrealized gains on equity securities significantly increased to $3.376 million for the six months ended June 30, 2025, from $0.129 million in the prior year.
• The company's revolving credit facility maturity date was extended to March 22, 2027, enhancing financial flexibility.

Negatives

• American Southern (Property & Casualty segment) experienced a deterioration in underwriting performance, with its combined ratio increasing from 99.1% to 101.5% for the six months ended June 30, 2025, indicating an underwriting loss.
• American Southern's loss ratio increased from 76.3% to 77.5% and its expense ratio increased from 22.8% to 24.0% for the six-month period.
• The company continues to have an identified and unremediated material weakness in internal control over financial reporting related to reviewing insurance reserves and deferred acquisition costs within the life and health segment.
• Remediation efforts for the material weakness have taken longer than previously anticipated due to unforeseen complexities in actuarial software systems.

Risks

• The effects of macroeconomic conditions and general economic uncertainty.
• Unexpected developments in the health care or insurance industries affecting providers or individuals, including cost or availability of services, or tax consequences.
• Disruption to the financial markets.
• Unanticipated increases in the rate, number, and amounts of claims outstanding.
• Inability to remediate the identified material weakness in internal control over financial reporting.
• The level of performance of reinsurance companies under reinsurance contracts and the availability, pricing, and adequacy of reinsurance.
• Changes in stock markets, interest rates, or other financial markets, including potential effects on statutory capital levels.
• Uncertain effect of regulatory and market-driven changes in practices relating to incentive compensation to brokers, agents, and other producers.
• Potential impact of public health emergencies.
• Incidence and severity of catastrophes, both natural and man-made.
• Possible occurrence of terrorist attacks.
• Stronger than anticipated competitive activity.
• Unfavorable judicial or legislative developments.
• Potential effect of regulatory developments, including those that could increase business costs and required capital levels.
• Ability to distribute products through distribution channels.
• Uncertain effect of emerging claim and coverage issues.
• Effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements.
• Information technology system failures or network disruptions.
• Risks related to cybersecurity matters, such as breaches of computer networks or loss of unauthorized access to data.

Future Outlook

Management believes that existing cash balances, along with expected dividends, fees, and tax-sharing payments from subsidiaries, and potential future financing arrangements, will enable the company to meet its liquidity requirements for the foreseeable future. The company expects the new internal-use software for actuarial calculations to be substantially ready for its intended use in the second half of 2025, with extensions to other product lines operational by September 30, 2025. The adoption of ASU 2018-12 (Accounting for Long-Duration Contracts) is expected to have a material impact on consolidated financial statements, effective for interim periods beginning after December 15, 2025.

Management Comments

• The increase in net income for the three and six months ended June 30, 2025, was primarily the result of increases in premium revenue within the inland marine line of business in property and casualty operations, as well as increases in the Medicare supplement and group accident and health lines of business within life and health operations.
• The increase in net income was also contributed to by an increase in unrealized gains on equity securities and favorable development in the Medicare supplement line of business.
• The issuers of fixed maturity investments have the ability to service their obligations and the company does not intend to sell these investments before recovery of their amortized cost bases.
• Management is not aware of any current recommendations by regulatory authorities that, if implemented, would have a material adverse effect on the company's liquidity, capital resources, or operations.
• The design of the controls surrounding the process of reviewing insurance reserves and deferred acquisition costs within the life and health segment was not effective, constituting a material weakness.
• Despite the material weakness, actions taken prior to filing prevented any identified material misstatements to financial statements, and no changes were made to historical financial statements.
• Full development and implementation of the independent calculation system for actuarial values has required more time than previously anticipated due to unforeseen complexities.

Industry Context

The insurance industry is currently navigating a dynamic environment characterized by fluctuating interest rates, which impact investment portfolios, and evolving healthcare costs, which affect life and health segments. The company's significant unrealized losses on fixed maturities reflect the elevated interest rate environment, a common challenge for insurers holding long-duration assets. The growth in Medicare supplement and group accident and health lines aligns with broader demographic trends and demand for health-related insurance products. The property and casualty segment's performance, particularly in automobile liability and physical damage, is influenced by factors like claims frequency, severity, and inflationary pressures on repair costs.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company is, and expects to continue to be, involved in various claims and lawsuits incidental to and arising in the ordinary course of its business. Management does not expect any such known claims to have a material effect on financial condition or results of operations.

Related Party Transactions

• The company has 55,000 shares of Series D preferred stock outstanding, all held by an affiliate of the company's controlling shareholder. Accrued but unpaid dividends on this preferred stock totaled $0.2 million at June 30, 2025.

Stakeholder Impact

• Shareholders: Positive impact due to significant swing to net income and improved EPS, but tempered by ongoing internal control weakness and mixed segment performance.
• Employees: No direct impact mentioned, but ongoing internal control remediation may involve additional workload for finance and actuarial teams.
• Customers: No direct impact mentioned, but premium increases in certain P&C lines (e.g., automobile liability) could affect policyholders.
• Suppliers: No direct impact mentioned.
• Creditors: Positive impact from improved financial performance and extended revolving credit facility maturity, but the material weakness in internal controls could be a concern for some.

Next Steps

• Continue remediation efforts for the material weakness in internal control over financial reporting, with extensions of the independent calculation system expected to be operational by September 30, 2025.
• Monitor the impact of the 'One Big Beautiful Bill Act of 2025' (OBBBA) on financials, although management does not anticipate a material impact.
• Prepare for the material impact on consolidated financial statements from the adoption of ASU 2018-12 (Accounting for Long-Duration Contracts), effective for interim periods beginning after December 15, 2025.

Key Dates

Recommendation

The company demonstrated a strong financial rebound, moving from a net loss to a net income, driven by robust premium growth and a significant turnaround in its life and health segment's underwriting profitability. This indicates effective strategic execution in key business areas. However, the persistent material weakness in internal controls over financial reporting, despite ongoing remediation efforts and delays, introduces an element of uncertainty regarding the reliability of financial reporting. Additionally, the property and casualty segment's underwriting performance deteriorated, offsetting some of the positive momentum. While the overall financial trajectory is positive, the unresolved control issues and mixed segment performance warrant a cautious 'hold' stance until the internal control weakness is fully remediated and consistent profitability across all segments is demonstrated.

Keywords

Insurance, Life Insurance, Health Insurance, Property and Casualty Insurance, Medicare Supplement, Financial Services, SEC Filing, Quarterly Report, Underwriting, Investment Income, Internal Controls, Risk Management